Multi-Omics and Single-Cell Omics: New Tools in Drug Target Discovery
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-04 · 44 (4) · 759-762
DOI: 10.1161/atvbaha.124.320686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-04. Verfasst von Joseph Loscalzo. Beteiligte Einrichtung: Division of Cardiovascular Medicine and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical …. Hauptthemen laut MEDLINE: Multiomics, Genomics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Loscalzo, J. (2024). Multi-Omics and Single-Cell Omics: New Tools in Drug Target Discovery. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(4), 759-762. https://doi.org/10.1161/atvbaha.124.320686
Vancouver
Loscalzo J. Multi-Omics and Single-Cell Omics: New Tools in Drug Target Discovery. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(4):759-762. doi:10.1161/atvbaha.124.320686
BibTeX
@article{Loscalzo2024,
author = {Loscalzo, Joseph},
title = {Multi-Omics and Single-Cell Omics: New Tools in Drug Target Discovery},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
volume = {44},
number = {4},
pages = {759--762},
doi = {10.1161/atvbaha.124.320686}
}
EUVIMED